[1] RUSSWURM S,WIEDERHOLD M,OBERHOFFER M,et al.Molecular aspects and natural source of procalcitonin[J].Clinical Chemistry & Laboratory Medicine,1999,37(8):789-797. [2] MEISNER M.Pathobiochemistry and clinical use of procalcitonin[J].Clinica Chimica Acta,2003,323(1):17-29. [3] KONRAD R,MICHAEL M.Biomarkers in the critically ill patient:Procalcitonin[J].Critical Care Clinics,2011,27(2):253-263. [4] MATWIYOFF G N,PRAHL J D,MILLER R J,et al.Immune regulation of procalcitonin:A biomarker and mediator of infection[J].Inflammation Research,2012,61(5):401-409. [5] GOGGS R,MILLOWAY M,TROIA R,et al.Plasma procalcitonin concentrations are increased in dogs with sepsis[J].Veterinary Record Open,2018,5(1):248-255. [6] RUIZ R,CABALLERO J C,RUIZ-SANMARTIN J,et al.Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock.A prospective pilot study[J].Medicina Intensiva,2012,36(7):475-480. [7] CHRISTINA W,ANNA P,BRUNKHORST F M,et al.Procalcitonin as a diagnostic marker for sepsis:A systematic review and meta-analysis[J].Lancet Infectious Diseases,2013,13(5):426-435. [8] LIAPPIS A P,NYLEN E S,YOON B,et al.Exogenous procalcitonin evokes a pro-inflammatory cytokine response[J].Inflammation Research,2011,60(2):203-207. [9] OTTO C M.Clinical trials in spontaneous disease in dogs:A new paradigm for investigations of sepsis[J].Journal of Veterinary Emergency & Critical Care,2010,17(4):359-367. [10] QIAN T,TIAN W,LI W,et al.Clonning and expression of procalcitonin and preparation of its polyclonal antibody[J].Chinese Journal of Cellular & Molecular Immunology,2013,9(5):504-506. [11] SCHUETZ P,BRETSCHER C,BERNASCONI L,et al.Overview of procalcitonin assays and procalcitonin guided protocols for the management of patients with infections and sepsis[J].Expert Review of Molecular Diagnostics,2017,17(6):593-601. [12] CHOUK M,VERHOEVEN F,SONDAG M,et al.Value of serum procalcitonin for the diagnosis of bacterial septic arthritis in daily practice in rheumatology[J].Clinical Rheumatology,2019,4(16):1-9. [13] SCHUETZ P,WIRZ Y.SAGER R.Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections a patient level meta-analysis[J].Lancet Infectious Diseases,2018,18(1):95-107. [14] HAYATI F,AZNAN Z,NASIRUDDIN N,et al.Serum procalcitonin predicts anastomotic leaks in colorectal surgery[J].Asian Pacific Journal of Cancer Prevention,2017,18(7):1821-1825. [15] GIUNTI M,PELI A,BATTILANI M,et al.Evaluation of CALC-Ⅰ gene (CALCA) expression in tissues of dogs with signs of the systemic inflammatory response syndrome[J].Veterinary Emergency and Critical Care,2010,20(5):523-527. [16] 白妍,赵蕾,杜威威,等.鸡传染性支气管炎病毒HH06株囊膜蛋白多克隆抗体制备及生物学功能检测[J].中国畜牧兽医,2016,43(8):1967-1974. BAI Y,ZHAO L,DU W W,et al.Preparation of polyclonal antibody against recombinant E protein of IBV HH06 strain and its biological function[J].China Animal Husbandry & Veterinary Medicine,2016,43(8):1967-1974.(in Chinese) [17] 刘云,贾斌,石峰,等.奶牛早孕因子重组蛋白的原核表达、纯化及多克隆抗体的制备[J].中国畜牧兽医,2015,42(4):877-882. LIU Y,JIA B,SHI F,et al.Prokaryotic expression,purification of early pregnancy factor protein of the dairy cattle and preparation of polyclonal antibody against it[J].China Animal Husbandry & Veterinary Medicine,2015,42(4):877-882.(in Chinese) [18] 高闪电,常惠芸,独军政,等.一种高效、稳定的可溶性原核表达载体的构建及应用[J].华北农学报,2009,24(6):46-49. GAO S D,CHANG H Y,DU J Z,et al.Construction and application of an efficient,stable soluble prokaryotic expression vector[J].Acta Agriculturae Boreali-Sinica,2009,24(6):46-49.(in Chinese) [19] 陈洁,张志萍,谢惠芳.基因重组降钙素原蛋白在大肠杆菌中的克隆表达及纯化[J].检验医学,2008,23(3):240-244. CHEN J,ZHANG Z P,XIE H F,et al.Expression and purification of recombinant procalciton in Escherichia coli[J].Laboratory Medicine,2008,23(3):240-244.(in Chinese) [20] 贾海英,马海梅,丁剑冰,等.细粒棘球绦虫重组pET30a-EgA31疫苗的构建和诱导表达[J].科技导报,2009,8:55-58. JIA H Y,MA H M,DING J B,et al.Construction of the recombinant plasimid pET30a-EgA31 of Echinococcus granulosus and its induced expression in E.coli[J].Science & Technology Review,2009,8:55-58.(in Chinese) [21] 陆海,吴薇,曾庆银,等.大肠杆菌BL21(DE3)中表达重组蛋白的研究[J].北京林业大学学报,2001,23(6):1-4. LU H,WU W,ZENG Q Y,et al.The expression analysis of recombinant protein in Escherichia coli BL21(DE3)[J].Journal of Beijing Forestry university,2001,23(6):1-4.(in Chinese) [22] POROWIŃSKA D,WUJAK M,ROSZEK K,et al.Prokaryotic expression systems[J].Postepy Higieny I Medycyny Doswiadczalnej,2013,67:119-129. [23] MAKRIDES S C.Strategies for achieving high-level expression of genes in Escherichia coli[J].Microbiological Reviews,1996,60(3):512-538. [24] CASTELLI G P,POGNANI C,CITA M,et al.Procalcitonin,C reactive protein,white blood cells and SOFA score in ICU:Diagnosis and monitoring of sepsis[J].Minerva Anestesiologica,2006,72(1-2):69-80. [25] CARRICK J B,BEGG A P.Peripheral blood leukocytes[J].Veterinary Clinics of North America Equine Practice,2008,24(2):239-259. [26] GEERING B,STOECKLE C,CONUS S,et al.Living and dying for inflammation:Neutrophils,eosinophils,basophils[J].Trends in Immunology,2013,34(8):398-409. [27] El-TAHAN R R,GHONEIM A M,El-MASHAD N.TNF-α gene polymorphisms and expression[J].SpringerPlus,2016,5(1):1508. [28] HUNTER C A,JONES S A.IL-6 as a keystone cytokine in health and disease[J].Nature Immunology,2015,16(5):448-457. [29] ROSE-JOHN S,WINTHROP K,CALABRESE L.The role of IL-6 in host defence against infections:Immunobiology and clinical implications[J].Nature Reviews Rheumatology,2017,13(7):399-409. [30] KUZI S,AROCH I,PELEG K,et al.Canine procalcitonin messenger RNA expression[J].Journal of Veterinary Diagnostic Investigation,2008,20(5):629-633. [31] ROBERTA T,MASSIMO G,STEFANO C,et al.Cell-free DNA,high-mobility group box-1,and procalcitonin concentrations in dogs with gastric dilatation-volvulus syndrome[J].Frontiers in Veterinary Science,2018,5(9):67-72. [32] WACKER C,PRKNO A,et al.Procalcitonin as a diagnostic marker for sepsis:A systematic review and meta-analysis[J].Lancet Infectious Diseases,2013,13(5):426-435. [33] GIUNTI M,TROIA R,GOGGS R.Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis[J].Bmc Veterinary Research,2018,14(1):111-120. |